ConductScience.org, home

Paper32190815

Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.

Agrawal V and 10 others. JNCI Cancer Spectr, 2020. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management. Papers, record 32190815. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32190815

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.
PubMed
Journal
JNCI Cancer Spectr
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
0.83
iCite
Revised in PubMed
2021-05-13
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Agrawal VVaibhavhttps://orcid.org/0000-0002-6383-3777
2Dinh PC JrPaul C
3Fung CChunkit
4Monahan POPatrick O
5Althouse SKSandra K
6Norton KKelli
7Cary CClint
8Einhorn LLawrence
9Fossa SDSophie D
10Adra NNabil
11Travis LBLois B

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA157823NCI NIH HHSUnited StatesR01CA157823PubMed

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in32955976Re: Adverse Health Outcomes among US Testicular Cancer Survivors after Cisplatin-Based Chemotherapy vs Surgical Management.https://conductscience.org/library/papers/32955976

Source PubMed

Download CSV of comments and corrections

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125261162Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.Pain2014https://conductscience.org/library/papers/25261162PubMed
223535024Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care.Cancer Epidemiol Biomarkers Prev2013https://conductscience.org/library/papers/23535024PubMed
310025925Different factors influencing the expression of Raynaud's phenomenon in men and women.Arthritis Rheum1999https://conductscience.org/library/papers/10025925PubMed
422184390Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer.J Clin Oncol2012https://conductscience.org/library/papers/22184390PubMed
524971421Health behaviors among testicular cancer survivors.J Community Support Oncol2014https://conductscience.org/library/papers/24971421PubMed
617848741Long-term complications of platinum-based chemotherapy in testicular cancer survivors.Med Oncol2007https://conductscience.org/library/papers/17848741PubMed
720225230Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.Cancer2010https://conductscience.org/library/papers/20225230PubMed
817445663Health behaviors and depressive symptoms in testicular cancer survivors.Urology2007https://conductscience.org/library/papers/17445663PubMed
921499930Quality of life among testicular cancer survivors: a case-control study in the United States.Qual Life Res2011https://conductscience.org/library/papers/21499930PubMed
1014663349Risk factors for tinnitus in a population of older adults: the blue mountains hearing study.Ear Hear2003https://conductscience.org/library/papers/14663349PubMed
118652248Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.Eur J Cancer1995https://conductscience.org/library/papers/8652248PubMed
1215220040Peripheral neuropathy.Lancet2004https://conductscience.org/library/papers/15220040PubMed
1327354478Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.J Clin Oncol2016https://conductscience.org/library/papers/27354478PubMed
148427676The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors.Arch Otolaryngol Head Neck Surg1993https://conductscience.org/library/papers/8427676PubMed
1525095826Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus.Heart2014https://conductscience.org/library/papers/25095826PubMed
1627761128Positive Association between Tinnitus and Arterial Hypertension.Front Neurol2016https://conductscience.org/library/papers/27761128PubMed
1727169992Long-term health effects among testicular cancer survivors.J Cancer Surviv2016https://conductscience.org/library/papers/27169992PubMed
1871004Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer.Ann Intern Med1977https://conductscience.org/library/papers/71004PubMed
1926599185Distal Symmetric Polyneuropathy: A Review.JAMA2015https://conductscience.org/library/papers/26599185PubMed
2027253694Cancer treatment and survivorship statistics, 2016.CA Cancer J Clin2016https://conductscience.org/library/papers/27253694PubMed

See all 27 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42571160Guideline recommendations versus real-world management in early-stage testicular cancer: a multicenter survey of contemporary practice.Ther Adv Med Oncol2026https://conductscience.org/library/papers/42571160PubMed
40507307Impact of Testicular Cancer on the Socio-Economic Health, Sexual Health, and Fertility of Survivors-A Questionnaire Based Survey.Cancers (Basel)2025https://conductscience.org/library/papers/40507307PubMed
40272552Long-term side effects of testicular cancer and treatment (observational study of mortality and morbidity in testicular cancer survivors).Support Care Cancer2025https://conductscience.org/library/papers/40272552PubMed
40002159Knowledge Deficit About How Chemotherapy Affects Long-Term Survival in Testicular Tumor Patients.Cancers (Basel)2025https://conductscience.org/library/papers/40002159PubMed
39966729Preoperative semen quality is superior to the quality shortly after orchiectomy in patients with testicular germ cell tumour - a retrospective study from two centres in Germany.Basic Clin Androl2025https://conductscience.org/library/papers/39966729PubMed
39924670Comparison of carboplatin-based chemotherapy versus cisplatin-based chemotherapy in the treatment of malignant gonadal germ cell tumor: a systematic review and meta-analysis.J Gynecol Oncol2025https://conductscience.org/library/papers/39924670PubMed
39532799Late side effects of testicular cancer and treatment: a comprehensive review.Discov Oncol2024https://conductscience.org/library/papers/39532799PubMed
39337038Radiological Assessment of Different Retroperitoneal Lymph Node Measurements in Stage 1 Testicular Cancer Patients: Impact on Clinical Stage and Treatment.J Clin Med2024https://conductscience.org/library/papers/39337038PubMed
38067334Radiomics and Clinicopathological Characteristics for Predicting Lymph Node Metastasis in Testicular Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/38067334PubMed
35852781Hypertension in Cancer Survivors.Curr Hypertens Rep2022https://conductscience.org/library/papers/35852781PubMed
34804849Narrative review of developing new biomarkers for decision making in advanced testis cancer.Transl Androl Urol2021https://conductscience.org/library/papers/34804849PubMed
34286139Erectile dysfunction among testicular cancer survivors: A systematic review and meta-analysis.Heliyon2021https://conductscience.org/library/papers/34286139PubMed
34107893Revised manuscript R2, clean version are serum levels of 25-hydroxy vitamin D reduced following orchiectomy in testicular cancer patients?Basic Clin Androl2021https://conductscience.org/library/papers/34107893PubMed
34021196Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours.Sci Rep2021https://conductscience.org/library/papers/34021196PubMed
33922599Targeting Cancer Stem Cells with Differentiation Agents as an Alternative to Genotoxic Chemotherapy for the Treatment of Malignant Testicular Germ Cell Tumors.Cancers (Basel)2021https://conductscience.org/library/papers/33922599PubMed
32190816Back to the Future-Moving Forward for Testicular Cancer Survivors.JNCI Cancer Spectr2020https://conductscience.org/library/papers/32190816PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
VIP7432PubTator's text mininghttps://conductscience.org/library/genes/7432

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32190815

GET https://conductscience.org/api/papers/v1/32190815/references?page=2